{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T07:07:23Z","timestamp":1784790443257,"version":"3.55.0"},"reference-count":27,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:00:00Z","timestamp":1692662400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>(1) Background: Albinism is characterized by a lack of pigment in eyes, hair, and skin and developmental changes in the eye such as foveal hypoplasia. Patients require optical rehabilitation due to low vision, refractive errors, and photosensitivity. We aimed to assess vision-related quality of life in patients with albinism and to evaluate how this was affected by optical rehabilitation. (2) Methods: Patients with ocular or oculocutaneous albinism were invited for the study. Free-of-charge optical rehabilitation was provided as needed, including filters, glasses for near or distance, contact lenses, magnifiers or binoculars. Vision-related quality of life was assessed prior to and after optical rehabilitation using the visual function questionnaire (VFQ39) and the effect of optical rehabilitation was evaluated after accounting for age, gender, and visual acuity. (3) Results: Seventy-eight patients filled out the VFQ39 at the initial visit. Fifty patients (64.1%) returned the questionnaire 3\u20136 months after optical rehabilitation. The mean age of included patients was 35.9 years (standard deviation 16.6), and their best corrected distance visual acuity was 56 ETDRS letters (range 3\u201381). The VFQ39 composite score improved significantly from a median of 62.5 (range 14.2\u201377.0) to 76.5 (20.6\u201399.6). Significant improvements were seen for ocular pain, social functioning, mental health, role difficulties, and dependency, whereas self-assessed distance or near visual functions did not change. (4) Conclusions: Optical rehabilitation improved the self-reported vision-related quality of life in Danish patients with albinism on a number of parameters related to leading an independent and worry-free life, whereas visual improvement for distance and near tasks was likely limited by the nature of the disease and by the fact that most patients already had access to some optical aids prior to the study.<\/jats:p>","DOI":"10.3390\/jcm12175451","type":"journal-article","created":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T08:01:21Z","timestamp":1692777681000},"page":"5451","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Vision-Related Quality of Life in Danish Patients with Albinism and the Impact of an Updated Optical Rehabilitation"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7642-2726","authenticated-orcid":false,"given":"Kristian","family":"Lisbjerg","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Copenhagen University Hospital\u2014Righospitalet, 2600 Glostrup, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3092-0057","authenticated-orcid":false,"given":"Joaquim Torner","family":"Jordana","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Copenhagen University Hospital\u2014Righospitalet, 2600 Glostrup, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibeke N.","family":"Brandt","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Copenhagen University Hospital\u2014Righospitalet, 2600 Glostrup, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Kj\u00f8lholm","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Copenhagen University Hospital\u2014Righospitalet, 2600 Glostrup, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9375-1510","authenticated-orcid":false,"given":"Line","family":"Kessel","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Copenhagen University Hospital\u2014Righospitalet, 2600 Glostrup, Denmark"},{"name":"Department of Clinical Medicine, University of Copenhagen, 2200 Copenhagen N, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,8,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0039-6257(85)90077-3","article-title":"Albinism","volume":"30","author":"Kinnear","year":"1985","journal-title":"Surv. Ophthalmol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1167\/iovs.64.10.14","article-title":"Determining a Worldwide Prevalence of Oculocutaneous Albinism: A Systematic Review","volume":"64","author":"Kromberg","year":"2023","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/pcmr.12982","article-title":"Genetics of Non-Syndromic and Syndromic Oculocutaneous Albinism in Human and Mouse","volume":"34","author":"Hayashi","year":"2021","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00403-022-02335-1","article-title":"Oculocutaneous Albinism: Epidemiology, Genetics, Skin Manifestation, and Psychosocial Issues","volume":"315","author":"Ma","year":"2022","journal-title":"Arch. Dermatol. Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1136\/bjophthalmol-2020-316348","article-title":"Normal and Abnormal Foveal Development","volume":"106","author":"Thomas","year":"2020","journal-title":"Br. J. Ophthalmol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"8921","DOI":"10.1523\/JNEUROSCI.23-26-08921.2003","article-title":"Organization of the Visual Cortex in Human Albinism","volume":"23","author":"Hoffmann","year":"2003","journal-title":"J. Neurosci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/s41433-021-01656-1","article-title":"Reporting on Australian Childhood Visual Impairment: The First 10 Years","volume":"36","author":"Silveira","year":"2022","journal-title":"Eye"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1038\/eye.2017.206","article-title":"Impact of Healthcare Strategies on Patterns of Paediatric Sight Impairment in a Developed Population: 1984\u20132011","volume":"31","author":"Shirley","year":"2017","journal-title":"Eye"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.det.2020.08.012","article-title":"Factors Affecting Quality of Life for People Living with Albinism in Botswana","volume":"39","author":"Anshelevich","year":"2021","journal-title":"Dermatol. Clin."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1590\/abd1806-4841.20153498","article-title":"Quality of Life in Patients with Oculocutaneous Albinism","volume":"90","author":"Maia","year":"2015","journal-title":"An. Bras. Dermatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jaapos.2008.10.008","article-title":"Evaluation of Vision-Specific Quality-of-Life in Albinism","volume":"13","author":"Kutzbach","year":"2009","journal-title":"J. Am. Assoc. Pediatr. Ophthalmol. Strabismus"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1080\/13816810.2021.1881979","article-title":"Genotype-Phenotype Associations in Danish Patients with Ocular and Oculocutaneous Albinism","volume":"42","author":"Kessel","year":"2021","journal-title":"Ophthalmic Genet."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.optom.2022.07.002","article-title":"Photosensitivity and Filter Efficacy in Albinism\u2730","volume":"16","author":"Hansen","year":"2023","journal-title":"J. Optom."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/13816810.2017.1342134","article-title":"A Novel Iris Transillumination Grading Scale Allowing Flexible Assessment with Quantitative Image Analysis and Visual Matching","volume":"39","author":"Wang","year":"2018","journal-title":"Ophthalmic Genet."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/j.ophtha.2018.08.003","article-title":"The Phenotypic Spectrum of Albinism","volume":"125","author":"Kruijt","year":"2018","journal-title":"Ophthalmology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/j.ophtha.2011.01.028","article-title":"Structural Grading of Foveal Hypoplasia Using Spectral-Domain Optical Coherence Tomography: A Predictor of Visual Acuity?","volume":"118","author":"Thomas","year":"2011","journal-title":"Ophthalmology"},{"key":"ref_17","first-page":"A4290","article-title":"Danish Version of Visual Function Questionnaire-25 and Its Use in Age-Related Macular Degeneration","volume":"58","author":"Andersen","year":"2011","journal-title":"Dan. Med. Bull."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Mangione, C.M. (2000). NEI VFQ-25 Scoring Algorithm. Version 2000. The National Eye Institute 25-Item Visual Function Questionnaire (VFQ-25), National Eye Institute.","DOI":"10.1037\/t08622-000"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0886-3350(00)00562-9","article-title":"Normal Values for the Pelli-Robson Contrast Sensitivity Test","volume":"27","author":"Laitinen","year":"2001","journal-title":"J. Cataract Refract. Surg."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1007\/s00417-021-05434-3","article-title":"Quality of Life in Patients with Glaucoma Assessed by 39-Item National Eye Institute Visual Functioning Questionnaire (NEI VFQ-39)","volume":"260","author":"Szegedi","year":"2022","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jcrs.2009.11.019","article-title":"Remediating Serious Flaws in the National Eye Institute Visual Function Questionnaire","volume":"36","author":"Pesudovs","year":"2010","journal-title":"J. Cataract Refract. Surg."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/aos.15102","article-title":"Vision-Related Quality of Life and Visual Ability in Patients with Autosomal Dominant Optic Atrophy","volume":"100","author":"Bek","year":"2022","journal-title":"Acta Ophthalmol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/cxo.12562","article-title":"The Use of Contact Lenses in Low Vision Rehabilitation: Optical and Therapeutic Applications","volume":"100","author":"Vincent","year":"2017","journal-title":"Clin. Exp. Optom."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3389750","DOI":"10.1155\/2023\/3389750","article-title":"Rehabilitation Methods for Patients with Geographic Atrophy Due to Age-Related Macular Degeneration and Effects of Rehabilitation on Quality of Life","volume":"2023","author":"Batioglu","year":"2023","journal-title":"J. Ophthalmol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.2147\/OPTH.S258783","article-title":"Visual Impairment and Mental Health: Unmet Needs and Treatment Options","volume":"14","author":"Demmin","year":"2020","journal-title":"Clin. Ophthalmol."},{"key":"ref_26","first-page":"307","article-title":"The Basic VRS-Effect Study: Clinical Trial Outcomes and Cost-Effectiveness of Low Vision Rehabilitation in Portugal","volume":"12","author":"Senra","year":"2022","journal-title":"Ophthalmol. Ther."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11136-020-02647-7","article-title":"Trajectories of Health-Related Quality of Life among People with a Physical Disability and\/or Chronic Disease during and after Rehabilitation: A Longitudinal Cohort Study","volume":"30","author":"Seves","year":"2021","journal-title":"Qual. Life Res."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/17\/5451\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:39:51Z","timestamp":1760128791000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/17\/5451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,22]]},"references-count":27,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["jcm12175451"],"URL":"https:\/\/doi.org\/10.3390\/jcm12175451","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,22]]}}}